DAPANEU M
| Dosage: As directed by the Registered Medical Practitioner. |
| Side-effects: Genitourinary tract infections (such as urinary tract infections or genital yeast infections) due to increased glucose excretion in urine with dapagliflozin. Hypoglycemia (low blood sugar) when used in combination with other antidiabetic agents. Gastrointestinal disturbances such as diarrhea, nausea, vomiting, or abdominal discomfort, particularly with metformin. |
| Contraindications: Acute or chronic metabolic acidosis including diabetic ketoacidosis Severe renal impairment. |
| Presentation: Dapaneu M Tablets are available in Alu-Alu pack of 15 tablets. |
Description
Dapaneu-M
Dapagliflozin 10mg + Metfromin ER 500/1000mg
Description:
Dapaneu-M is a combination of three antidiabetic medications.
Dapagliflozin increases urinary glucose excretion and reduces blood glucose levels.
Metformin decreases the amount of glucose absorbed from the food and the amount of glucose made by the liver. Metformin also increases the body’s response to insulin, a natural substance that controls the amount of glucose in the blood.
Indications:
Dapaneu-M tablet is commonly used for the management of type 2 diabetes mellitus (T2DM) to improve glycemic control and reduce the risk of diabetes-related complications. It may be prescribed as an adjunct to diet and exercise in individuals whose diabetes is not adequately controlled with metformin alone or in combination with other antidiabetic agents.
Composition:
Dapaneu-M
Each film-coated bilayered tablet contains :
Dapagliflozin propanediol monohydrate eq. to Dapagliflozin 10mg
Metformin Hydrochloride IP (As extended release form) ER 500 mg
Colours : Ferric oxide red USP-NF
& Titanium Dioxide IP
